March 16, 2015
Unlike other big drugmakers facing do-or-die pressure to merge, Switzerland's Roche has found a third way: Invest in a web of research partners and diversify into diagnostic equipment.
August 07, 2005
This content is from:
Citi’s troupe overseen by Andrew Baum slips from second place to third on this roster, while garnering a runner-up spot in Biotechnology
February 02, 2016
February 04, 2014
Germany’s Curetis AG has secured €9.6 million in venture capital financing.
October 26, 2011
Vaulting from runner-up to second place — the firm’s highest ranking to date — is the four-strong Citi troupe piloted by Andrew Baum.
February 18, 2015